About

David Ward is Formulation and Manufacturing Lead for Intertek Melbourn. He has worked in the pharmaceutical and device development sectors for more than 20 years across innovative pharma companies and device design and product development, specialising in formulation, analysis and clinical production approaches for orally inhaled and nasal drug products. He has worked across many device types including pressurised metereddose inhalers, dry-powder inhalers, nasal products and nebulisers.

Contributions

NASAL

INTRANASAL DELIVERY OF BIOLOGIC THERAPEUTICS AND VACCINES

David Ward looks at how the nasal route of drug administration offers the potential to improve the delivery of biologics, even for very complex molecules such as antibodies – and why strategic formulation is required to make this a reality.

More contributions

NASAL

OPTIMISING NASAL DRUG PRODUCTS FOR SYSTEMIC DELIVERY

David Ward discusses the benefits of systemic nasal delivery, describes a number of formulation strategies, and explains how to optimise absorption through properly informed formulation and device selection.